Cardiff Lexington grants 500K options to director

A Cardiff Lexington Corp director received 500,000 stock options exercisable at $0.1162, expiring in 2031.

Rhea-AI Filing Summary

Cardiff Lexington Corp (CDIX) reported that director Johnson Gillard B. III received a grant of 500,000 stock options on September 8, 2026. The options are exercisable for Cardiff Lexington common stock at an exercise price of $0.1162 per share and expire on September 8, 2031. Following this grant, he holds 500,000 options directly.

Insider Trade Summary

Grant/Award: 500,000 shares

Grant/Award 1 txn

Insider Johnson Gillard B. III

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	500,000	$0.00	$0.00

Holdings After Transaction: Stock Option — 500,000 contracts (Direct)

Key Figures

Options granted: 500,000 options Exercise price: $0.1162 per share Expiration date: September 8, 2031 +1 more

4 metrics

Options granted 500,000 options Stock option grant to director on September 8, 2026

Exercise price $0.1162 per share Conversion or exercise price of the stock options

Expiration date September 8, 2031 Expiration of stock options granted to the director

Post-grant option holdings 500,000 options Total derivative securities held directly after the transaction

Key Terms

Stock Option, underlying security, Rule 10b5-1

3 terms

Stock Option financial

"The security reported is a Stock Option with common stock as the underlying security"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

underlying security financial

"The underlying security title is listed as Common Stock for this option"

Rule 10b5-1 regulatory

"A Rule 10b5-1 checkbox indicates whether trades are under a trading plan"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CDIX disclose for Johnson Gillard B. III?

Cardiff Lexington Corp disclosed that director Johnson Gillard B. III received a grant of 500,000 stock options on September 8, 2026, giving him the right to acquire Cardiff Lexington common stock under the terms of the award.

What is the exercise price of the new stock options granted at CDIX?

The stock options granted to the Cardiff Lexington Corp director have an exercise price of $0.1162 per share for the underlying common stock, as stated in the filing.

When do the newly granted CDIX stock options expire?

The stock options granted to the Cardiff Lexington Corp director on September 8, 2026 expire on September 8, 2031, providing a five-year term to exercise the award.

How many CDIX options does the director hold after this transaction?

After the September 8, 2026 grant, the Cardiff Lexington Corp director is reported to hold 500,000 stock options directly, according to the post-transaction holdings in the Form 4.

Was the CDIX option grant reported under a Rule 10b5-1 trading plan?

No. The filing indicates that the Rule 10b5-1 checkbox is not affirmed, so this option grant is not reported as being made under a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 04:16 PM Accepted by SEC EDGAR 09/15/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Johnson Gillard B. III

(Last) (First) (Middle)

C/O CARDIFF LEXINGTON CORPORATION

710 EAST MAIN STREET

(Street)

LEXINGTON KENTUCKY 40502

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cardiff Lexington Corp [ CDIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$0.1162	09/08/2026		A		500,000		09/08/2026	09/08/2031	Common Stock	500,000	$0	500,000	D

Explanation of Responses:

	/s/ Gillard B. Johnson, III	09/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)